Trius Therapeutics (TSRX) Secures a $25 Million Committed Equity Financing Facility With Terrapin Opportunity, L.P.  
9/4/2012 9:49:18 AM

SAN DIEGO, Aug. 31, 2012 (GLOBE NEWSWIRE) -- Trius Therapeutics, Inc. (Nasdaq:TSRX) announced today that it has obtained a committed equity financing facility under which it may from time to time sell up to $25 million of its registered common stock to Terrapin Opportunity, L.P., over a 24-month period. Trius is not obligated to utilize any of the $25 million facility and remains free to enter into and consummate other equity and debt financing transactions, subject to certain restrictions.